New
HealthMore in Health→
Study Links Persistent Mucosal CAR-T Cells to Enterocolitis After BCMA Therapy
Key Takeaways
- A Nature Medicine study published online 23 September 2026 examines enterocolitis in multiple myeloma patients treated with BCMA-directed CAR-T therapy.
- The paper's title highlights two linked findings: persistence of mucosal CAR-T cells and inflammatory remodeling in the gut.
- The work is described as a multimodal analysis, drawing on multiple lines of evidence rather than a single assay or time point.
- Enterocolitis is difficult to diagnose because infections, medications, and immune-driven inflammation can produce overlapping symptoms.
DE
DT Editorial Team··via nature.com